Olga Husson1, Judith B Prins1, Suzanne E J Kaal2, Simone Oerlemans3, Wendy B Stevens4, Bradley Zebrack5, Winette T A van der Graaf2,6, Lonneke V van de Poll-Franse3,7,8. 1. a Department of Medical Psychology , Radboud University Medical Center , Nijmegen , The Netherlands. 2. b Department of Medical Oncology , Radboud University Medical Center , Nijmegen , The Netherlands. 3. c Netherlands Comprehensive Cancer Organisation (IKNL) , Utrecht , The Netherlands. 4. d Department of Haematology , Radboud University Medical Center , Nijmegen , The Netherlands. 5. e University of Michigan School of Social Work , Ann Arbor , MI , USA. 6. f Institute of Cancer Research and Royal Marsden NHS Foundation Trust , London , UK. 7. g CoRPS-Centre of Research on Psychology in Somatic diseases, Department of Medical and Clinical Psychology , Tilburg University , Tilburg , The Netherlands. 8. h Division of Psychosocial Oncology and Epidemiology , Netherlands Cancer Institute , Amsterdam , The Netherlands.
Abstract
BACKGROUND: Trying to simultaneously achieve developmental milestones and cope with a life-threatening disease may place adolescents and young adults (AYAs) at risk for impaired health-related quality of life (HRQoL) later in life. The aim of this study was to examine differences in HRQoL between AYA lymphoma survivors and a normative population and to determine sociodemographic, clinical and long-term symptom-related factors associated with HRQoL. MATERIAL AND METHODS: This study was part of a longitudinal, population-based survey among lymphoma survivors diagnosed between 1999 and 2012. The AYA survivor sample (18-39 years at time diagnosis) was compared to a sex- and age-matched normative population on HRQoL (EORTC-QLQ-C30) and psychological distress (HADS). Multiple linear regression analyses were conducted to determine factors associated with HRQoL among survivors. RESULTS: One hundred and ninety-eight AYA lymphoma survivors (58%) responded to the study invitation. Compared to an age- and sex-matched normative population (N = 380), significantly and clinically relevant poorer HRQoL was observed for AYA lymphoma survivors in seven specific domains of HRQoL: physical, role, cognitive, emotional, social functioning, fatigue and financial difficulties (all p < 0.05). In addition, AYA lymphoma survivors less often had a spouse/partner and more often had a lower educational level compared to the normative population. Linear regression analyses showed that being unemployed, female gender, having one or more comorbid conditions, high levels of fatigue and psychological distress were most strongly associated with HRQoL. CONCLUSIONS: These findings identify specific domains of life in which cancer has a significant and long-term impact for AYA lymphoma survivors. Future investigations are needed to identify and test administrations and timing of psychosocial support interventions having potential to reduce long-term late effects in specific HRQoL domains and promote function and adaptability after cancer treatment.
BACKGROUND: Trying to simultaneously achieve developmental milestones and cope with a life-threatening disease may place adolescents and young adults (AYAs) at risk for impaired health-related quality of life (HRQoL) later in life. The aim of this study was to examine differences in HRQoL between AYA lymphoma survivors and a normative population and to determine sociodemographic, clinical and long-term symptom-related factors associated with HRQoL. MATERIAL AND METHODS: This study was part of a longitudinal, population-based survey among lymphoma survivors diagnosed between 1999 and 2012. The AYA survivor sample (18-39 years at time diagnosis) was compared to a sex- and age-matched normative population on HRQoL (EORTC-QLQ-C30) and psychological distress (HADS). Multiple linear regression analyses were conducted to determine factors associated with HRQoL among survivors. RESULTS: One hundred and ninety-eight AYA lymphoma survivors (58%) responded to the study invitation. Compared to an age- and sex-matched normative population (N = 380), significantly and clinically relevant poorer HRQoL was observed for AYA lymphoma survivors in seven specific domains of HRQoL: physical, role, cognitive, emotional, social functioning, fatigue and financial difficulties (all p < 0.05). In addition, AYA lymphoma survivors less often had a spouse/partner and more often had a lower educational level compared to the normative population. Linear regression analyses showed that being unemployed, female gender, having one or more comorbid conditions, high levels of fatigue and psychological distress were most strongly associated with HRQoL. CONCLUSIONS: These findings identify specific domains of life in which cancer has a significant and long-term impact for AYA lymphoma survivors. Future investigations are needed to identify and test administrations and timing of psychosocial support interventions having potential to reduce long-term late effects in specific HRQoL domains and promote function and adaptability after cancer treatment.
Authors: Lillian Chen; Jackelyn B Payne; Kaylin V Dance; Conner B Imbody; Cathy D Ho; Amy A Ayers; Christopher R Flowers Journal: Clin Lymphoma Myeloma Leuk Date: 2019-10-19
Authors: Suzanne E J Kaal; Emma K Lidington; Judith B Prins; Rosemarie Jansen; Eveliene Manten-Horst; Petra Servaes; Winette T A van der Graaf; Olga Husson Journal: J Clin Med Date: 2021-04-22 Impact factor: 4.241
Authors: Rachel M Taylor; Lorna A Fern; Julie Barber; Javier Alvarez-Galvez; Richard Feltbower; Stephen Morris; Louise Hooker; Martin G McCabe; Faith Gibson; Rosalind Raine; Dan P Stark; Jeremy S Whelan Journal: BMJ Open Date: 2019-04-20 Impact factor: 2.692
Authors: Lonneke V van de Poll-Franse; Nicole Horevoorts; Dounya Schoormans; Sandra Beijer; Nicole P M Ezendam; Olga Husson; Simone Oerlemans; Sanne B Schagen; Geja J Hageman; Katrijn Van Deun; Corina van den Hurk; Mies van Eenbergen; Floortje Mols Journal: J Natl Cancer Inst Date: 2022-06-13 Impact factor: 11.816
Authors: Elizabeth J Siembida; Bryce B Reeve; Brad J Zebrack; Mallory A Snyder; John M Salsman Journal: Psychooncology Date: 2020-10-30 Impact factor: 3.894